Invesco
MGNX icon

Invesco’s MacroGenics MGNX Stock Holding History

Invesco’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$325K Buy
112,373
+1,252
+1% +$2.67K ﹤0.01% 3310
2025
Q4 		$179K Buy
111,121
+26,668
+32% +$41.9K ﹤0.01% 3555
2025
Q3 		$142K Buy
84,453
+23,421
+38% +$37.9K ﹤0.01% 3628
2025
Q2 		$73.8K Sell
61,032
-7,345
-11% -$10.7K ﹤0.01% 3688
2025
Q1 		$86.8K Buy
68,377
+32,398
+90% +$84.6K ﹤0.01% 3646
2024
Q4 		$117K Buy
35,979
+1,231
+4% +$4.43K ﹤0.01% 3604
2024
Q3 		$114K Sell
34,748
-933
-3% -$3.63K ﹤0.01% 3600
2024
Q2 		$152K Buy
35,681
+4,471
+14% +$43.5K ﹤0.01% 3696
2024
Q1 		$459K Sell
31,210
-39,767
-56% -$601K ﹤0.01% 3370
2023
Q4 		$683K Sell
70,977
-38
-0.1% -$263 ﹤0.01% 3063
2023
Q3 		$331K Sell
71,015
-437,909
-86% -$2.18M ﹤0.01% 3405
2023
Q2 		$2.72M Buy
508,924
+157,278
+45% +$970K ﹤0.01% 2531
2023
Q1 		$2.52M Buy
351,646
+36,876
+12% +$222K ﹤0.01% 2547
2022
Q4 		$2.11M Buy
314,770
+253,719
+416% +$1.39M ﹤0.01% 2629
2022
Q3 		$212K Sell
61,051
-2,322
-4% -$8.88K ﹤0.01% 3659
2022
Q2 		$186K Buy
63,373
+4,438
+8% +$23.3K ﹤0.01% 3745
2022
Q1 		$519K Buy
58,935
+18,301
+45% +$202K ﹤0.01% 3368
2021
Q4 		$653K Sell
40,634
-2,883
-7% -$54.3K ﹤0.01% 3271
2021
Q3 		$911K Sell
43,517
-8,860
-17% -$213K ﹤0.01% 3147
2021
Q2 		$1.41M Buy
52,377
+6,094
+13% +$178K ﹤0.01% 2989
2021
Q1 		$1.47M Sell
46,283
-2,992,770
-98% -$72.7M ﹤0.01% 2897
2020
Q4 		$69.5M Sell
3,039,053
-1,436,502
-32% -$33.1M 0.02% 899
2020
Q3 		$113M Sell
4,475,555
-2,668
-0.1% -$72.8K 0.04% 594
2020
Q2 		$125M Sell
4,478,223
-1,348
-0% -$23.4K 0.04% 506
2020
Q1 		$26.1M Sell
4,479,571
-19,251
-0.4% -$175K 0.01% 1091
2019
Q4 		$48.9M Buy
4,498,822
+10,467
+0.2% +$104K 0.02% 1024
2019
Q3 		$57.3M Buy
4,488,355
+2,278
+0.1% +$32.8K 0.02% 932
2019
Q2 		$76.1M Buy
4,486,077
+4,467,474
+24,015% +$76.7M 0.02% 804
2019
Q1 		$334K Buy
18,603
+1,947
+12% +$33.7K ﹤0.01% 3455
2018
Q4 		$212K Buy
16,656
+2,048
+14% +$34.3K ﹤0.01% 3544
2018
Q3 		$313K Sell
14,608
-293,256
-95% -$6.25M ﹤0.01% 3598
2018
Q2 		$6.36M Buy
307,864
+293,486
+2,041% +$6.61M ﹤0.01% 1993
2018
Q1 		$362K Sell
14,378
-1,993
-12% -$48.4K ﹤0.01% 3445
2017
Q4 		$311K Buy
16,371
+203
+1% +$3.79K ﹤0.01% 3437
2017
Q3 		$299K Buy
16,168
+865
+6% +$15K ﹤0.01% 3453
2017
Q2 		$268K Buy
15,303
+63
+0.4% +$1.2K ﹤0.01% 3518
2017
Q1 		$283K Sell
15,240
-1,261
-8% -$24.3K ﹤0.01% 3523
2016
Q4 		$337K Sell
16,501
-31,881
-66% -$802K ﹤0.01% 3425
2016
Q3 		$1.45M Buy
48,382
+26,857
+125% +$799K ﹤0.01% 2754
2016
Q2 		$581K Sell
21,525
-22,604
-51% -$510K ﹤0.01% 3169
2016
Q1 		$827K Buy
44,129
+11,050
+33% +$210K ﹤0.01% 3009
2015
Q4 		$1.02M Sell
33,079
-3,855
-10% -$117K ﹤0.01% 2924
2015
Q3 		$791K Sell
36,934
-15,851
-30% -$497K ﹤0.01% 3040
2015
Q2 		$2M Sell
52,785
-2,055
-4% -$67.5K ﹤0.01% 2609
2015
Q1 		$1.72M Buy
54,840
+46,710
+575% +$1.58M ﹤0.01% 2706
2014
Q4 		$285K Buy
+8,130
New +$203K ﹤0.01% 3521

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco's MGNX Position: Q1 2026 in Review

Invesco increased its MacroGenics (MGNX) stake by 1.1% in Q1 2026, buying an estimated $2.67K and bringing the position to 112,373 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #3310.

Invesco first reported a position in MGNX in Q4 2014 and has held it in 46 quarters since. The position peaked at $125M in Q2 2020. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Invesco held 112,373 shares of MacroGenics worth $325K as of Q1 2026.
  • Invesco bought 1,252 MacroGenics shares in Q1 2026, an estimated $2.67K.
  • MacroGenics made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3310 holding.
  • Invesco first reported a position in MacroGenics in Q4 2014 and has held it in 46 quarters since.
  • Invesco's MacroGenics position peaked at $125M in Q2 2020.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.